[go: up one dir, main page]

Zhang et al., 2019 - Google Patents

An interaction between BRG1 and histone modifying enzymes mediates lipopolysaccharide‐induced proinflammatory cytokines in vascular endothelial cells

Zhang et al., 2019

Document ID
10853211381163752140
Author
Zhang Y
Yuan Y
Li Z
Chen H
Fang M
Xiao P
Xu Y
Publication year
Publication venue
Journal of cellular biochemistry

External Links

Snippet

Vascular inflammation is the culprit for a host of human diseases. The underlying mechanism, however, is not definitively elucidated. In the present study, we investigated the interplay between different epigenetic factors during lipopolysaccharide (LPS) induced …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6802—General aspects
    • C12Q1/6809—Sequence identification involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid

Similar Documents

Publication Publication Date Title
Zhang et al. An interaction between BRG1 and histone modifying enzymes mediates lipopolysaccharide‐induced proinflammatory cytokines in vascular endothelial cells
Lee et al. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential
Miao et al. Enhancer-associated long non-coding RNA LEENE regulates endothelial nitric oxide synthase and endothelial function
Kang et al. IFN-γ selectively suppresses a subset of TLR4-activated genes and enhancers to potentiate macrophage activation
Qi et al. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer
Lio et al. TET enzymes augment activation-induced deaminase (AID) expression via 5-hydroxymethylcytosine modifications at the Aicda superenhancer
Sakurai et al. The lncRNA DRAIC/PCAT29 locus constitutes a tumor-suppressive nexus
Li et al. LncRNA Lnc‐APUE is repressed by HNF4α and promotes G1/S phase transition and tumor growth by regulating MiR‐20b/E2F1 Axis
Guetg et al. The NoRC complex mediates the heterochromatin formation and stability of silent rRNA genes and centromeric repeats
Gonzalez et al. A lncRNA regulates alternative splicing via establishment of a splicing-specific chromatin signature
Di Giorgio et al. Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells
Choudhry et al. Extensive regulation of the non‐coding transcriptome by hypoxia: role of HIF in releasing paused RNA pol2
Håkelien et al. The regulatory landscape of osteogenic differentiation
Wu et al. Epigenetic reprogramming and post-transcriptional regulation during the epithelial–mesenchymal transition
Baer et al. Epigenetic silencing of miR‐708 enhances NF‐κB signaling in chronic lymphocytic leukemia
Petrie et al. Effects on prostate cancer cells of targeting RNA polymerase III
Poulard et al. A post‐translational modification switch controls coactivator function of histone methyltransferases G9a and GLP
Cuadrado et al. The contribution of cohesin-SA1 to gene expression and chromatin architecture in two murine tissues
Simboeck et al. DPY30 regulates pathways in cellular senescence through ID protein expression
Yu et al. Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression
Shangguan et al. TOB1-AS1 suppresses non-small cell lung cancer cell migration and invasion through a ceRNA network
Yang et al. Long noncoding RNA LINC00319 regulates ROMO1 expression and promotes bladder cancer progression via miR‐4492/ROMO1 axis
Li et al. Alteration of chromatin high‐order conformation associated with oxaliplatin resistance acquisition in colorectal cancer cells
Cheishvili et al. DNA methylation controls unmethylated transcription start sites in the genome in trans
Mazzu et al. Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity